The formation of viroplasm-like structures by the rotavirus NSP5 protein is calcium regulated and directed by a C-terminal helical domain.
The rotavirus NSP5 protein directs the formation of viroplasm-like structures (VLS) and is required for viroplasm formation within infected cells. In this report, we have defined signals within the C-terminal 21 amino acids of NSP5 that are required for VLS formation and that direct the insolubility and hyperphosphorylation of NSP5. Deleting C-terminal residues of NSP5 dramatically increased the solubility of N-terminally tagged NSP5 and prevented NSP5 hyperphosphorylation. Computer modeling and analysis of the NSP5 C terminus revealed the presence of an amphipathic alpha-helix spanning 21 C-terminal residues that is conserved among rotaviruses. Proline-scanning mutagenesis of the predicted helix revealed that single-amino-acid substitutions abolish NSP5 insolubility and hyperphosphorylation. Helix-disrupting NSP5 mutations also abolished localization of green fluorescent protein (GFP)-NSP5 fusions into VLS and directly correlate VLS formation with NSP5 insolubility. All mutations introduced into the hydrophobic face of the predicted NSP5 alpha-helix disrupted VLS formation, NSP5 insolubility, and the accumulation of hyperphosphorylated NSP5 isoforms. Some NSP5 mutants were highly soluble but still were hyperphosphorylated, indicating that NSP5 insolubility was not required for hyperphosphorylation. Expression of GFP containing the last 68 residues of NSP5 at its C terminus resulted in the formation of punctate VLS within cells. Interestingly, GFP-NSP5-C68 was diffusely dispersed in the cytoplasm when calcium was depleted from the medium, and after calcium resupplementation GFP-NSP5-C68 rapidly accumulated into punctate VLS. A potential calcium switch, formed by two tandem pseudo-EF-hand motifs (DxDxD), is present just upstream of the predicted alpha-helix. Mutagenesis of either DxDxD motif abolished the regulatory effect of calcium on VLS formation and resulted in the constitutive assembly of GFP-NSP5-C68 into punctate VLS. These results reveal specific residues within the NSP5 C-terminal domain that direct NSP5 hyperphosphorylation, insolubility, and VLS formation in addition to defining residues that constitute a calcium-dependent trigger of VLS formation. These studies identify functional determinants within the C terminus of NSP5 that regulate VLS formation and provide a target for inhibiting NSP5-directed VLS functions during rotavirus replication.
Sen
Adrish
A
Department of Medicine, SUNY at Stony Brook, Stony Brook, NY 11794, USA.
Sen
Nandini
N
Mackow
Erich R
ER
D000595:Amino Acid Sequence; D000818:Animals; D019556:COS Cells; D002118:Calcium / Q000378:metabolism; D002522:Chlorocebus aethiops; D003593:Cytoplasm / Q000378:metabolism; D049452:Green Fluorescent Proteins / Q000378:metabolism; D008969:Molecular Sequence Data; D010766:Phosphorylation; D011392:Proline / Q000737:chemistry; D011485:Protein Binding; D017433:Protein Structure, Secondary; D017434:Protein Structure, Tertiary; D012401:Rotavirus / Q000737:chemistry; D017361:Viral Nonstructural Proteins / Q000737:chemistry* / Q000378:metabolism
C434828:NSP5 protein, rotavirus group A; D017361:Viral Nonstructural Proteins; D049452:Green Fluorescent Proteins; D011392:Proline; D002118:Calcium
J Virol. 2006 Nov;80(21):10829-35
16928740
J Virol. 2005 May;79(10):6194-206
15858004
Proteins. 2006 Nov 15;65(3):643-55
16981205
J Virol. 2007 Mar;81(5):2128-37
17182692
Proteins. 1999 Nov 15;37(3):499-507
10591109
J Gen Virol. 2000 Mar;81(Pt 3):821-30
10675420
Proteins. 2001 Sep 1;44(4):479-83
11484225
J Gen Virol. 2005 Jun;86(Pt 6):1609-17
15914838
J Virol. 2005 Aug;79(15):10023-31
16014962
J Gen Virol. 2006 Feb;87(Pt 2):429-38
16432031
J Virol. 2006 Feb;80(4):1807-16
16439537
J Virol. 2006 Jun;80(12):6061-71
16731945
Lancet. 2006 Jul 22;368(9532):323-32
16860702
J Virol. 2006 Aug;80(16):8283-4; author reply 8284-5
16873287
Curr Top Microbiol Immunol. 2006;309:169-87
16909900
Curr Top Microbiol Immunol. 2006;309:189-219
16913048
J Virol. 2002 Apr;76(7):3461-70
11884570
J Cell Sci. 2002 Jun 15;115(Pt 12):2485-95
12045219
Arch Virol. 2002 Oct;147(10):1899-911
12376752
J Pept Sci. 2003 Jun;9(6):386-92
12846484
J Virol. 2003 Nov;77(22):12184-92
14581555
J Mol Biol. 2004 Jan 9;335(2):631-40
14672669
Virology. 2004 Feb 5;319(1):94-106
14967491
J Gen Virol. 2004 Mar;85(Pt 3):625-34
14993647
J Mol Biol. 2004 Oct 29;343(4):971-84
15476814
J Gen Virol. 2004 Nov;85(Pt 11):3285-90
15483242
J Gen Virol. 1982 Dec;63(2):457-67
6296288
Virus Res. 1984;1(2):133-52
6099654
J Cell Biol. 1986 Feb;102(2):457-68
3511070
J Virol. 1989 Sep;63(9):3974-82
2548010
J Gen Virol. 1990 Sep;71 ( Pt 9):2073-83
2170574
Proteins. 1991;9(1):12-22
2017432
Virology. 1991 May;182(1):8-16
1850914
J Gen Virol. 1993 Mar;74 ( Pt 3):525-30
8383185
J Virol. 1994 Jan;68(1):251-7
8254736
J Virol. 1995 Sep;69(9):5763-72
7637021
J Biol Chem. 1995 Nov 17;270(46):27876-9
7499261
J Gen Virol. 1996 Sep;77 ( Pt 9):2059-65
8811003
J Virol. 1997 Jan;71(1):34-41
8985320
J Virol. 1997 Jan;71(1):138-44
8985332
J Virol. 1998 Aug;72(8):6398-405
9658080
Arch Virol. 1998;143(9):1711-22
9787656
J Gen Virol. 1998 Nov;79 ( Pt 11):2679-86
9820143
Biochem Cell Biol. 1998;76(2-3):313-23
9923700
J Gen Virol. 1999 Feb;80 ( Pt 2):333-9
10073692
Protein Eng. 1999 May;12(5):395-405
10360980
Virology. 1962 Oct;18:192-205
13960197
Proc Natl Acad Sci U S A. 2004 Nov 16;101(46):16304-9
15520389
Biochemistry. 2005 Jan 11;44(1):411-6
15628883
Biochemistry. 2005 Jan 25;44(3):905-14
15654746
J Gen Virol. 2005 May;86(Pt 5):1481-7
15831961
Mem Inst Oswaldo Cruz. 2006 Sep;101(6):603-11
17072471